Clinical Trials Browser

Metastatic Castration-sensitive Prostate Cancer × niraparib × 90 days × Clear all

NCT04497844 2026-02-13

AMPLITUDE

Phase 3 Active not recruiting

696 enrolled 15 charts 1 FDA

Metastatic Castration-sensitive Prostate Cancer